Status:

RECRUITING

Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders

Lead Sponsor:

Charite University, Berlin, Germany

Conditions:

Psychotic Disorders

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

A rater-blinded randomized controlled trial with a parallel-group design is utilized, comprised of yoga-based group intervention (YoGI) in the experimental condition, and treatment as usual (TAU) in t...

Detailed Description

Psychiatrists and psychologists at the ward for psychotic disorders identify eligible participants and invite them to participate in the study. An eligibility screening is held by the study assistant ...

Eligibility Criteria

Inclusion

  • male and female participants
  • treated as psychiatric inpatients at the psychosis ward or in the social-psychiatric day clinic
  • ≥18 years
  • diagnosis of a schizophrenia-spectrum disorder according to the Diagnostical and Statistical Manual 5th edition) and the International Statistical Classification of Diseases and Related Health Problems(ICD-10) code F2
  • ability to give informed consent
  • willingness and ability to engage in psychotherapeutic group therapy
  • low to moderate psychotic state indicated with a score of ≤ 6 for each item at the Positive scale of the Positive and Negative Syndrome Scale (PANSS, Peralta \& Cuesta, 1994)

Exclusion

  • a score \> 6, suggesting an acute psychotic episode with severe psychotic symptoms (Peralta\& Cuesta, 1994)
  • acute suicidality, assessed by item eight of the Calgary Depression Scale for Schizophrenia \> 1 (Addington, Addington, Maticka-Tyndale, \& Joyce, 1992)
  • any neurological disorders that may affect cognitive functioning
  • acute substance abuse other than nicotine and prescribed medication
  • conflicting co-therapy such as electroconvulsive therapy or ketamine treatment

Key Trial Info

Start Date :

January 28 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2025

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT04730518

Start Date

January 28 2021

End Date

December 30 2025

Last Update

February 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Charité Universitätsmedizin Berlin, Campus Benjamin Franklin

Steglitz, State of Berlin, Germany, 1220